Evidence map›Paper›PMID 31373844›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2019

Attenuation of amyloid-β generation by atypical protein kinase C-mediated phosphorylation of engulfment adaptor PTB domain containing 1 threonine 35.

Dennis Dik-Long Chau, Kristen Wing-Yu Yung, William Wai-Lun Chan, Ying An, Yan Hao, Ho-Yin Edwin Chan, Jacky Chi-Ki Ngo, Kwok-Fai Lau

Open access · bronzeAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Transcription-translation error:Informatics in medicine unlocked · 2021
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Dennis Dik-Long ChauFaculty of Science, School of Life Sciences, The Chinese University of Hong Kong, Hong Kong, China.
Kristen Wing-Yu YungFaculty of Science, School of Life Sciences, The Chinese University of Hong Kong, Hong Kong, China.
William Wai-Lun ChanFaculty of Science, School of Life Sciences, The Chinese University of Hong Kong, Hong Kong, China.
Ying AnFaculty of Science, School of Life Sciences, The Chinese University of Hong Kong, Hong Kong, China.
Yan HaoFaculty of Science, School of Life Sciences, The Chinese University of Hong Kong, Hong Kong, China.
Ho-Yin Edwin ChanFaculty of Science, School of Life Sciences, The Chinese University of Hong Kong, Hong Kong, China.
Jacky Chi-Ki NgoFaculty of Science, School of Life Sciences, The Chinese University of Hong Kong, Hong Kong, China.
Kwok-Fai LauFaculty of Science, School of Life Sciences, The Chinese University of Hong Kong, Hong Kong, China.
Chinese University of Hong Kong · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyloid-β (Aβ) is derived from the proteolytic processing of amyloid precursor protein (APP), and the deposition of extracellular Aβ to form amyloid plaques is a pathologic hallmark of Alzheimer's disease (AD). Although reducing Aβ generation and accumulation has been proposed as a means of treating the disease, adverse side effects and unsatisfactory efficacy have been reported in several clinical trials that sought to lower Aβ levels. Engulfment adaptor phosphotyrosine-binding (PTB) domain containing 1 (GULP1) is a molecular adaptor that has been shown to interact with APP to alter Aβ production. Therefore, the modulation of the GULP1-APP interaction may be an alternative approach to reducing Aβ. However, the mechanisms that regulate GULP1-APP binding remain elusive. As GULP1 is a phosphoprotein, and because phosphorylation is a common mechanism that regulates protein interaction, we anticipated that GULP1 phosphorylation would influence GULP1-APP interaction and thereby Aβ production. We show here that the phosphorylation of GULP1 threonine 35 (T35) reduces GULP1-APP interaction and suppresses the stimulatory effect of GULP1 on APP processing. The residue is phosphorylated by an isoform of atypical PKC (PKCζ). Overexpression of PKCζ reduces both GULP1-APP interaction and GULP1-mediated Aβ generation. Moreover, the activation of PKCζ

Indexed as

Protein Processing, Post-TranslationalAdaptor Proteins, Signal TransducingAlzheimer DiseaseAmyloid beta-PeptidesAmyloid beta-Protein PrecursorAnimalsCell Line, TumorCHO CellsCricetulusHEK293 CellsHumansPhosphorylationProtein BindingProtein Kinase CThreonineAdaptor Proteins, Signal TransducingAmyloid beta-PeptidesAmyloid beta-Protein PrecursorGULP1 protein, humanPKC-3 proteinProtein Kinase CThreonineAlzheimer’s diseaseamyloid precursor proteinGULP1

Identifiers

PMID31373844
PMCPMC6902715
OpenAlexW2964793597

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.